| Literature DB >> 30112215 |
Obiora Shedrach Ejiofor1, Onyinye Mercy Ajunwa2, Chijioke Elias Ezeudu3, George Ogonna Emechebe1, Kenneth Nchekwube Okeke1, Christian Chukwuemeka Ifezulike1, Ifeoma Mercy Ekejindu4, Jude Nnaemeka Okoyeh5, Eunice Ogonna Osuala6, Angus Nnamdi Oli2.
Abstract
BACKGROUND: Neonatal infection refers to the infection of the newborn during the first twenty-eight days of life. It is one of the causes of infant morbidity and mortality worldwide. The aim of the study is to determine the relative contribution of the different pathogens to the overall disease burden. It will also determine the mechanisms of virulence of these pathogens that cause neonatal infections at Chukwuemeka Odumegwu Ojukwu University Teaching Hospital (COOUTH), Awka.Entities:
Year: 2018 PMID: 30112215 PMCID: PMC6077539 DOI: 10.1155/2018/4801247
Source DB: PubMed Journal: J Pathog ISSN: 2090-3057
Figure 1Selection criteria.
Figure 2Clinical assessments of the selected babies (reasons for admission).
The prevalence of the isolates in relation to gender and maturity of the neonates.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||
|
| 23.00 |
| 7 | 5 |
| 10 | 2 |
|
|
| 24.6 | 2 | 1 |
| 3 | 0 | ||
|
| 19.7 | 5 | 4 |
| 7 | 2 | ||
|
| 32.8 | 4 | 2 |
| 5 | 1 | ||
|
| ||||||||
|
|
|
|
|
|
| |||
Frequency of occurrence of the isolates.
|
|
| ||||
|---|---|---|---|---|---|
|
|
|
|
| ||
|
| 8 | 1 | 1 | 0 |
|
|
| 3 | 2 | 0 | 0 | |
|
| 4 | 4 | 0 | 1 | |
|
| 1 | 3 | 1 | 1 | |
|
| |||||
|
|
|
|
|
| |
|
|
|
|
|
| |
|
| |||||
The multidrugs resistance pattern of the isolates.
|
| % |
| |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
| 100 | 100 | 100 | 100 | 100 | 100 | 41.7 | 75 | 100 | 100 | 0 | 25 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 37.5 | |
|
| 100 | 100 | 100 | 100 | 100 | 100 | 33.4 | 12.5 | 83.3 | 87.5 | 16.7 | 12.5 | 100 | 100 | 100 | 100 | 33.3 | 100 | 33.3 | 75 | |
|
| 100 | 100 | 100 | 100 | 100 | 100 | 100 | 75 | 80 | 87.5 | 0 | 25 | 100 | 100 | 100 | 100 | 80 | 100 | 80 | 62.5 | |
|
| 100 | 100 | 100 | 100 | 100 | 100 | 50 | 100 | 75 | 90 | 0 | 10 | 100 | 100 | 100 | 100 | 100 | 90 | 100 | 100 | |
|
| |||||||||||||||||||||
KEY:
UC: umbilical cord swab samples and B: peripheral blood samples. Figures in brackets represent mean resistance of the isolates to the drugs tested. TIC: ticarcillin 75μg, KF: cephalothin 30μg, CAZ: ceftazidime 30 μg, C/S: ceftriaxone/sulbactam 30 μg, MEM: meropenem 10μg, LVD: levofloxacin 5 μg, CXM: cefuroxime 30 μg, PRL: piperacillin 110 μg, HVX: azithromycin 15 μg, and HFX: ceftriaxone 30 μg.
Virulence factors characterization of the isolates.
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
|
|
| |||
|
| Hyaluronidase | 0 | 0 | 8 | 6 |
|
| Proteases | 0 | 0 | 9 | 6 |
| |
| Lipases | 0 | 0 | 9 | 5 |
| |
| DNases | 0 | 0 | 9 | 6 |
| |
| Hemolysins | 12 | 3 | 7 | 5 |
| |
| Coagulase | 0 | 0 | 0 | 6 |
| |
| Superoxide dismutase | 9 | 3 | 0 | 0 |
| |
| Fibrinolysin | 0 | 0 | 2 | 6 |
| |
|
| ||||||
|
| Enterotoxins | 10 | 3 | 0 | 6 |
|
| Shiga toxin | 12 | 0 | 0 | 0 |
| |
| Acid resistance pH 3.5 | 10 | 3 | 8 | 6 |
| |
| Biofilm formation | 10 | 3 | 8 | 6 |
| |
| Lipopolysaccharide | 12 | 1 | 8 | 0 |
| |
| Haemoglobin utilization | 12 | 0 | 0 | 0 |
| |
|
| ||||||
|
|
|
|
|
| ||